Introduction 38
Typhoid and paratyphoid, collectively known as enteric fever, are among the most common 39 bacterial causes of morbidity worldwide, with the greatest burden in low-and middle-income 40 countries (GBD 2017 Typhoid and Paratyphoid Collaborators, 2019) . Salmonella 41 enterica subspecies enterica serovars Typhi (Salmonella Typhi) and Paratyphi (A, B and C), 42 etiologies of enteric fever, cause an estimated 14 million illnesses and 136,000 deaths annually. 43
44
In the pre-antibiotic era, enteric fever mortality rates exceeded 20% in many areas, but 45 ampicillin, chloramphenicol and co-trimoxazole were instrumental in reducing the rates to <1%. 46 Resistance to all three antibiotics (referred to as multidrug resistance, MDR) emerged in late 47 1980 's (Mirza et al., 1996 , predominantly due to the rise and subsequent continental migration 48 of H58 haplotype (now referred to as 4.3.1), which contained the resistance genes either on 49
IncH1 plasmids or integrated within the chromosome (Holt et al., 2011; Wong et al., 2015 Wong et al., , 50 2016 . Fluoroquinolones soon became the most-commonly prescribed antibiotic (White et al., 51 1996) , but since the 2000's there have been increasing reports of decreased fluoroquinolone 52 susceptibility due to the acquisition of chromosomal mutations in the DNA gyrase and 53 topoisomerase IV genes (Roumagnac et al., 2006; Chau et al., 2007 , Dimitrov et al., 2007 Pham 54 Thanh et al., 2016) . In Bangladesh, >99% of all Typhi and Paratyphi strains exhibit decreased 55 susceptibility to ciprofloxacin (Saha et al., 2018b) . In 2011, WHO recommended ceftriaxone or 56 azithromycin for treating Salmonella Typhi non-susceptible to fluroquinolones (Balasegaram et 57 al., 2012) . 58
59
Between 2009 and 2016, through our enteric fever surveillance (Saha et al., 2017) in the 83 inpatient departments of the two largest pediatric hospitals of Bangladesh, we isolated 939 84 Salmonella Typhi and 143 Paratyphi A strains. Twelve of the Typhi and one of the Paratyphi A 85 strains were resistant to azithromycin, with disc diameters of £12 mm, and minimum inhibitory 86 concentration (MIC) of ³32 µg/ml (Parry et al., 2015) . All 12 azithromycin-resistant Salmonella 87
Typhi strains were also MDR and were increasingly isolated since 2013 (Fig 1A) , marking 88 gradual emergence of azithromycin-resistant Salmonella Typhi in Bangladesh. All patients lived 89
in Dhaka city, known to be endemic for typhoid ( Figure S1 ). 90
91
Azithromycin resistant Salmonella Typhi harbors a mutation in the AcrB efflux pump 92
We sequenced the 12 azithromycin-resistant Typhi strains and found that all azithromycin-93 resistant strains belonged to genotype 4.3.1 (H58), the most common genotype found in South 94
Asia (Tanmoy et al., 2018; Wong et al., 2015) . In a whole-genome single nucleotide 95 polymorphism (SNP) tree, the 12 strains clustered together indicating that they are genetically 96 similar to one another and potentially arose for a single common parental strain ( Figure 1B ). To 97 identify the genetic basis of azithromycin resistance, we used three bioinformatic tools: SRST2 98 (Inouye et al., 2014) , Resfinder (Zankari et al., 2012) and CARD (Jia et al., 2017) and to evaluate 99 the results obtained from these tools, we tested antimicrobial susceptibility against a panel of 100 nine other antibiotics ( Figure 1C ). While the tools successfully predicted the observed 101 susceptibility patterns for the nine antibiotics, no known azithromycin resistance mechanism was 102 identified ( Figure 1C ). Using PlasmidFinder (Carattoli et al., 2014) we identified two plasmids 103 found in these Salmonella Typhi strains: (i) IncQ1 (12/12 strains), containing genes for 104 ampicillin, co-trimoxazole and chloramphenicol resistance, and (ii) InFIB (12/12 strains), a 105 plasmid commonly found in Salmonella Typhi strains (Kidgell et al., 2002; Park et al., 2018) . 106
Both these plasmids were also present in closely related azithromycin-sensitive strains. The lack 107 of known azithromycin-resistance genes indicated a novel mechanism of azithromycin resistance 108 in these strains. Salmonella Typhi strains isolated in Bangladesh previously (Tanmoy et al., 2018 We compared the sequences of these 12 azithromycin-resistant strains to that of 462 Typhi 127 strains that we had previously sequenced and genetically characterized (Tanmoy et al., 2018) . In 128 the WGS SNP tree, we identified four unique SNPs, present only in the 12 azithromycin-resistant 129 strains, three of which were non-synonymous: STY2741 (codes for purN, a glycinamidine 130 ribonucleotide transformyltransferase), STY1399 (codes for a hypothetical protein) and 131 STY0519 (codes for AcrB, an inner membrane permease) ( Figure 2A , Figure S2 ). For the first 132 two candidates, there is no evidence of their involvement in mediating antimicrobial resistance in 133 the literature. However, the third gene, acrB is part of a trans-envelope resistance-nodulation-134 division (RND) efflux pump that has been previously reported to transport macrolides including 135 azithromycin across the bacterial cell envelope, making it the most promising candidate 136 (Nakashima et al., 2011) . Mutations affecting expression of AcrB have been implicated in 137 macrolide resistance in Neisseria gonorrhoeae (Wadsworth et al., 2018) . Furthermore, laboratory 138 mutagenesis studies in Escherichia coli have shown that mutations in acrB can lead to higher 139 macrolide efflux thereby contributing to resistance (Ababou and Koronakis, 2016) . The SNP 140 observed in the 12 azithromycin-resistant Salmonella Typhi strains changed the arginine residue 141 (R) at position 717 to a glutamine (Q) ( Figure 2B ). R717 is a conserved residue on the 142 periplasmic cleft that acts as the entry portal for most drugs in AcrB ( Figure 2C ). In a previous 143 mutagenesis study, substitution of the arginine residue with an alanine (R717A) was found to 144 partially increase efflux of the macrolide erythromycin in E. coli (Yu et al., 2005) . 
R717 mutations in AcrB confer azithromycin resistance 168
We cloned acrB from azithromycin susceptible and resistant Salmonella Typhi strains into an E. 169 coli plasmid and introduced them into an E. coli strain that lacks the endogenous acrB (E. coli 170 ΔacrB). Compared to E. coli strains containing empty plasmid or wild type acrB, the strain 171 expressing AcrB-R717Q showed a smaller zone of disc clearance for both azithromycin (26.3 172 mm vs 16.7 mm, p = 0.0013) and erythromycin discs (22.3 mm vs 11.7 mm, p value = 0.0009) 173
and exhibited a 11-fold increase in azithromycin MIC (0.22 µg/ml vs 2.7 µg/ml, p = 0.0002) 174 ( Figure 3A , B). Certain AcrB mutations have previously been shown to effect transport of other 175 antibiotics such as ciprofloxacin (Blair et al., 2015) , but the R717Q mutation did not change the 176 susceptibility patterns for any other nine antibiotics we tested ( Figure S3 ). For further 177 confirmation of the effects of this mutation in Salmonella Typhi, we introduced the plasmids in 178 an azithromycin-sensitive Typhi strain and observed a 3-fold increase in MIC (5 µg/ml vs 13 179 µg/ml, p < 0.0001) in the presence of AcrB-R717Q ( Figure 3C ). The difference here is lower 180 compared to that seen in E. coli ΔacrB plausibly because the Typhi strain contains endogenous 181 wild-type AcrB competing against the exogenous AcrB-R717Q that we artificially introduced. 182
Taken together, these results confirm that AcrB-R717Q leads to increased macrolide resistance. 183 We conducted an extensive BLAST search to identify other typhoidal Salmonella strains with 193 mutations in AcrB the NCBI database and found only one Salmonella Typhi strain isolated in 194
Oceania in 2008 that contained the same R717Q mutation, however no AMR data were available 195 for this strain (Wong et al., 2015) . Interestingly, whole genome sequencing of the one 196 azithromycin-resistant Salmonella Paratyphi A strain identified during our surveillance showed 197 that this strain also contained a mutation in acrB which changed R717 to a leucine (L) (Figure 198 all previously widely used antimicrobials by Salmonella Typhi and Paratyphi, suggest we will 225 soon face strains resistant to all oral antibiotics. An azithromycin-resistant XDR strain would 226 shift enteric fever treatment from outpatient departments, where patients are currently treated 227 with oral azithromycin, to inpatient departments to be treated with injectable antibiotics like 228 carbapenems, thereby weighing down already struggling health systems in endemic regions 229 (Andrews et al., 2018; Saha et al., 2018a) . Moreover, with the dearth of novel antimicrobials in 230 the horizon, we risk losing our primary defense against widespread mortality from enteric fever. 231
In addition to continued surveillance and antimicrobial stewardship, it is imperative to roll-out 232 the recent WHO prequalified typhoid conjugate vaccine in endemic areas and decrease the 233 overall burden of typhoid. 234
235

Materials and Methods 236
Study site and population 237
In this study, we report data from enteric fever surveillance conducted in the inpatient 238 Blood culture was performed at the discretion of the treating physicians. We enrolled patients 245 with positive blood cultures for Salmonella Typhi or Paratyphi A. Blood cultures were 246 performed using standard methods (Saha et al., 2017) . We aseptically obtained 2-3 milliliters of 247 blood, which was inoculated into trypticase soy broth supplemented with sodium polyanethole 248 sulphonate (0.25%) and isovitalex (1%). Incubated blood culture bottles were sub-cultured on the 249 second, third, and fifth days of incubation. Identification of Salmonella Typhi/Paratyphi isolates 250 was confirmed using standard biochemical tests and agglutination with Salmonella species and 251 serovar-specific antisera (Ramel, Thermo Fisher Scientific). Laboratory methods for blood 252 culture and organism identification were consistent over the reporting period. China). We used SPAdes (Bankevich et al., 2012) to assemble the short paired-end reads into 269 contigs for downstream analyses. All the sequences have been submitted to EnteroBase and 270
NCBI (BioProject ID: PRJNA528114). 271 272
Bioinformatics analysis 273
For comparative genomic analysis, we compared the 12 azithromycin-resistant Salmonella Typhi 274 strains with 462 strains that were previously isolated and genetically characterized by our group 275 in Bangladesh (Tanmoy et al., 2018) . Using the ParSNP tool (Treangen et al., 2014) , we 276 constructed whole-genome SNP tree using all 475 genomes and determined the genotypes using 277 srst2 package (Inouye et al., 2014) . Ggtree was used to make the phylogenetic tree and overlay 278 the genotype data (Yu et al., 2017) . Srst2, ResFinder (Zankari et al., 2012) and CARD (Jia et al., 279 2017) were used to predict antimicrobial resistance markers, and PlasmidFinder (Carattoli et al., 280 2014) to identify the putative plasmids present in these strains. Finally, we compared the 281 resistant strains to all sensitive Salmonella Typhi strains manually to find SNPs exclusive to the 282 resistant strains (comparison to the most closely related 5 genomes are shown in Figure 1C ) 283 using the GinGR tool from the Harvest suite (Treangen et al., 2014) . To predict the function of 284 the SNPs on protein function, we examined the protein sequence and conducted structural 285 analyses (Figure 2) . 286 287
Macrolide susceptibility test in E. coli and Salmonella Typhi 288
We amplified the acrB genes from azithromycin-resistant Salmonella Typhi strain 5003 and 289
Paratyphi A strain 3144 and azithromycin-sensitive Typhi strain 4119 and Paratyphi A strain 290 4071 for downstream cloning. The genes were inserted into the multiple cloning site of 291 pHERD30T using Gibson assembly (Gibson et al., 2009) . We verified the sequences of all 292 inserted genes through Sanger sequencing. The plasmids were chemically transformed into 293 CaCl2-competent E. coli BW25112 DacrB strains, and electroporated into Typhi strain 4119 and 294 Paratyphi A strain 4071. E. coli strains with plasmids (with or without an insert) were tested for 295 susceptibility patterns for erythromycin, azithromycin, ampicillin, co-trimoxazole, 296 chloramphenicol, ciprofloxacin, levofloxacin, ceftriaxone, cefepime, cefixime and ceftazidime 297 using the disc diffusion method, and MIC was determined using azithromycin E-strips. Typhi 298 and Paratyphi strains with plasmids (with or without an insert) were tested for susceptibility 299 patterns for azithromycin using E-strips. 300 shown. The W195 is present close to the C-terminus and premature termination at this position is 505 predicted to not affect protein function. C) SNP on sty1399 that encodes a hypothetical protein 506 that is proposed to contain a B3/B4 tRNA-binding domain. The function of this protein is not 507 known and the SNP results in conversion of an alanine residue at position 34 to a threonine 508 residue. None of these two genes have been previously implicated in macrolide resistance. 509 
